Contrast Media/Contrast Agent Market
Global Contrast Media/Contrast Agent Market Size, Share & Trends Analysis Report by Type (Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media, and Barium-based Contrast Media), by Procedure (X-ray/Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Ultrasound), and by Indication (Cardiovascular Disorders, Oncology, Gastrointestinal Disorders, Neurological Disorders, and Others) Forecast Period 2021-2027
The global contrast media/contrast agent market is anticipated to grow at a CAGR of around 5% during the forecast period. The rising demand for fast and accurate diagnosis of severe diseases through MRI and CT scans is expected to propel the market growth during the forecast period. Additionally, technological advancement including 3D contrast media, syringeless power injectors are factors that are strongly supporting the market growth.
The contrast media has several side effects associated with it including allergic reactions or adverse effects on the body, vomiting, nausea, and others. These adverse side effects are expected to hamper the market growth of contrast media/contrast agents. Additionally, the lack of reimbursement policies and stringent rules and regulations for product approval in developing countries are also expected to hinder the market growth during the forecast period.
Impact of COVID-19 Pandemic on Global Contrast Media/Contrast Agent Market
X-ray and CT scanning had emerged as an effective method to detect the impact of COVID-19 on the lungs. The contrast media is used in ultrasound, MRI, X-ray, and CT scan imaging to improve inside the image. It enables the clear visibility of selected tissues, blood vessels, and organs of the body. It enables the radiologists to differentiate between normal and abnormal body parts. The rising prevalence of COVID-19 has thus further driven the market more.
Segmental Outlook
The global contrast media/contrast agent market is segmented based on the type, procedure, and indication. Based on the type, the market is segmented into iodinated contrast media, gadolinium-based contrast media, microbubble contrast media, and barium-based contrast media. Based on procedure, the market is sub-segmented into x-ray/CT, MRI, and ultrasound. Based on indication, the market is sub-segmented into cardiovascular disorders, oncology, gastrointestinal disorders, neurological disorders, and other indications.
Global Contrast Media/Contrast Agent Market Share by Type, 2020 (%)
The Iodinated Contrast Media Holds the Major Share in the Global Contrast Media/Contrast Agent Market
Iodinated contrast media holds the major share in the market owing to the increasing number of angioplasty procedures. It is a form of intravenous radiographic dye containing iodine that is used to enhance the visibility of vascular structures and organs during radiographic procedures. These iodinated contrast media are manufactured with a chemical modification of 2, 4, 6 tri-iodinated benzene rings. The growth of the segment is expected due to the rising usage of ionic contrast media.
The X-ray/CT scan segment under the procedure segmentation holds a prominent share in the market. The wide adoption of contrast agents in the economical X-ray/CT scans is the major driving factor for segmental growth. The cardiovascular disorders in the indication segmentation hold the major share in the market due to the high prevalence of CVD across the globe.
Regional Outlooks
The global contrast media/contrast agent market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, and Others), and the Rest of the World (the Middle East and Africa, and Latin America).
Global Contrast Media/Contrast Agent Market Growth, by Region 2021-2027
North America Holds the Major Share in the Global Contrast Media/Contrast Agent Market
The North American region holds the major share in the contrast media market, followed by Europe. The high prevalence of chronic diseases with the increasing adoption of minimally invasive procedures is the major driving factor for the market growth in these regions. Additionally, the well-developed healthcare infrastructure and availability of advanced technology are the other factors that are driving the market growth. Moreover, the Asia Pacific region exhibits a substantial growth rate in the global contrast media/contrast agent market.
Market Players Outlook
Some of the major companies serving the global contrast media/contrast agent market include Bayer AG, Bracco Imaging SPA, GE Healthcare, Lantheus Medical Imaging, Inc., Trivitron Healthcare Pvt. Ltd., Nano Therapeutics Pvt. Ltd., Biopharma Pvt. Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, Guerbet and InterSystems Corp. had partnered in November 2019 for the integration of Contrast&Care, contrast media injection management solution into the IT systems of hospital and medical imaging centers.
The Report Covers
• Market value data analysis of 2020 and forecast to 2027.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global contrast media/contrast agent market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Bayer AG
3.1.1.1. Overview
3.1.1.2. Financial Analysis
3.1.1.3. SWOT Analysis
3.1.1.4. Recent Developments
3.1.2. Bracco Imaging SPA
3.1.2.1. Overview
3.1.2.2. Financial Analysis
3.1.2.3. SWOT Analysis
3.1.2.4. Recent Developments
3.1.3. GE Healthcare
3.1.3.1. Overview
3.1.3.2. Financial Analysis
3.1.3.3. SWOT Analysis
3.1.3.4. Recent Developments
3.1.4. Lantheus Medical Imaging, Inc.
3.1.4.1. Overview
3.1.4.2. Financial Analysis
3.1.4.3. SWOT Analysis
3.1.4.4. Recent Developments
3.2. Key Strategy Analysis
4. Market Segmentation
4.1. Global Contrast Media/Contrast Agent Market by Type
4.1.1. Iodinated Contrast Media
4.1.2. Gadolinium-based Contrast Media
4.1.3. Microbubble Contrast Media
4.1.4. Barium-based Contrast Media
4.2. Global Contrast Media/Contrast Agent Market by Procedure
4.2.1. X-ray/Computed Tomography (CT)
4.2.2. Magnetic Resonance Imaging (MRI)
4.2.3. Ultrasound
4.3. Global Contrast Media/Contrast Agent Market by Indication
4.3.1. Cardiovascular Disorders
4.3.2. Oncology
4.3.3. Gastrointestinal Disorders
4.3.4. Neurological Disorders
4.3.5. Other Indications
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Acro Lifesciences (I) Pvt. Ltd.
6.2. Beijing Beilu Pharmaceutical Co., Ltd.
6.3. Congruent Pharmachem Pvt. Ltd.
6.4. iMax Diagnostic Imaging Ltd.
6.5. J.B. Chemicals and Pharmaceuticals Ltd.
6.6. Livealth Biopharma Pvt. Ltd.
6.7. Nano Therapeutics Pvt. Ltd.
6.8. Novalek Pharmaceuticals Pvt. Ltd.
6.9. Onko Ýlaç San. ve Tic. A.Þ.
6.10. Rege Imaging & Cine Films Pvt. Ltd.
6.11. SANOCHEMIA Pharmazeutika GmbH
6.12. Spago Nanomedical AB
6.13. Subhra Pharma Pvt. Ltd.
6.14. Taejoon Pharm
6.15. Trivitron Healthcare Pvt. Ltd.
6.16. Unijules Life Sciences
6.17. Unispire Biopharma Pvt. Ltd.
6.18. YZJ Group
1. GLOBAL CONTRAST MEDIA/CONTRAST AGENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
2. GLOBAL IODINATED CONTRAST MEDIA MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
3. GLOBAL GADOLINIUM-BASED CONTRAST MEDIA MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
4. GLOBAL MICROBUBBLE CONTRAST MEDIA MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
5. GLOBAL BARIUM-BASED CONTRAST MEDIA MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
6. GLOBAL CONTRAST MEDIA/CONTRAST AGENT MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2020-2027 ($ MILLION)
7. GLOBAL X-RAY/CT MARKET FOR CONTRAST MEDIA/CONTRAST AGENT RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
8. GLOBAL MRI MARKET FOR CONTRAST MEDIA/CONTRAST AGENT RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
9. GLOBAL ULTRASOUND MARKET FOR CONTRAST MEDIA/CONTRAST AGENT RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
10. GLOBAL CONTRAST MEDIA/CONTRAST AGENT MARKET RESEARCH AND ANALYSIS BY INDICATION, 2020-2027 ($ MILLION)
11. GLOBAL CARDIOVASCULAR DISORDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
12. GLOBAL ONCOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
13. GLOBAL GASTROINTESTINAL DISORDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
14. GLOBAL NEUROLOGICAL DISORDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
15. GLOBAL OTHER INDICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
16. GLOBAL CONTRAST MEDIA/CONTRAST AGENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
17. NORTH AMERICAN CONTRAST MEDIA/CONTRAST AGENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
18. NORTH AMERICAN CONTRAST MEDIA/CONTRAST AGENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
19. NORTH AMERICAN CONTRAST MEDIA/CONTRAST AGENT MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2020-2027 ($ MILLION)
20. NORTH AMERICAN CONTRAST MEDIA/CONTRAST AGENT MARKET RESEARCH AND ANALYSIS BY INDICATION, 2020-2027 ($ MILLION)
21. EUROPEAN CONTRAST MEDIA/CONTRAST AGENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
22. EUROPEAN CONTRAST MEDIA/CONTRAST AGENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
23. EUROPEAN CONTRAST MEDIA/CONTRAST AGENT MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2020-2027 ($ MILLION)
24. EUROPEAN CONTRAST MEDIA/CONTRAST AGENT MARKET RESEARCH AND ANALYSIS BY INDICATION, 2020-2027 ($ MILLION)
25. ASIA-PACIFIC CONTRAST MEDIA/CONTRAST AGENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
26. ASIA-PACIFIC CONTRAST MEDIA/CONTRAST AGENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
27. ASIA-PACIFIC CONTRAST MEDIA/CONTRAST AGENT MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2020-2027 ($ MILLION)
28. ASIA-PACIFIC CONTRAST MEDIA/CONTRAST AGENT MARKET RESEARCH AND ANALYSIS BY INDICATION, 2020-2027 ($ MILLION)
29. REST OF THE WORLD CONTRAST MEDIA/CONTRAST AGENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
30. REST OF THE WORLD CONTRAST MEDIA/CONTRAST AGENT MARKET RESEARCH AND ANALYSIS BY PROCEDURE, 2020-2027 ($ MILLION)
31. REST OF THE WORLD CONTRAST MEDIA/CONTRAST AGENT MARKET RESEARCH AND ANALYSIS BY INDICATION, 2020-2027 ($ MILLION)
1. GLOBAL CONTRAST MEDIA/CONTRAST AGENT MARKET SHARE BY TYPE, 2020 VS 2027 (%)
2. GLOBAL IODINATED CONTRAST MEDIA MARKET REGION BY GEOGRAPHY, 2020 VS 2027 (%)
3. GLOBAL GADOLINIUM-BASED CONTRAST MEDIA MARKET REGION BY GEOGRAPHY, 2020 VS 2027 (%)
4. GLOBAL MICRO BUBBLE CONTRAST MEDIA MARKET REGION BY GEOGRAPHY, 2020 VS 2027 (%)
5. GLOBAL BARIUM-BASED CONTRAST MEDIA MARKET REGION BY GEOGRAPHY, 2020 VS 2027 (%)
6. GLOBAL CONTRAST MEDIA/CONTRAST AGENT MARKET SHARE BY PROCEDURE, 2020 VS 2027 (%)
7. GLOBAL X-RAY/CT MARKET REGION BY GEOGRAPHY, 2020 VS 2027 (%)
8. GLOBAL MRI MARKET REGION BY GEOGRAPHY, 2020 VS 2027 (%)
9. GLOBAL ULTRASOUND MARKET REGION BY GEOGRAPHY, 2020 VS 2027 (%)
10. GLOBAL CONTRAST MEDIA/CONTRAST AGENT MARKET SHARE BY INDICATION, 2020 VS 2027 (%)
11. GLOBAL CARDIOVASCULAR DISORDERS MARKET REGION BY GEOGRAPHY, 2020 VS 2027 (%)
12. GLOBAL ONCOLOGY MARKET REGION BY GEOGRAPHY, 2020 VS 2027 (%)
13. GLOBAL GASTROINTESTINAL DISORDERS MARKET REGION BY GEOGRAPHY, 2020 VS 2027 (%)
14. GLOBAL NEUROLOGICAL DISORDERS MARKET REGION BY GEOGRAPHY, 2020 VS 2027 (%)
15. GLOBAL OTHER INDICATIONS MARKET REGION BY GEOGRAPHY, 2020 VS 2027 (%)
16. GLOBAL CONTRAST MEDIA/CONTRAST AGENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
17. US CONTRAST MEDIA/CONTRAST AGENT MARKET SIZE, 2020-2027 ($ MILLION)
18. CANADA CONTRAST MEDIA/CONTRAST AGENT MARKET SIZE, 2020-2027 ($ MILLION)
19. UK CONTRAST MEDIA/CONTRAST AGENT MARKET SIZE, 2020-2027 ($ MILLION)
20. FRANCE CONTRAST MEDIA/CONTRAST AGENT MARKET SIZE, 2020-2027 ($ MILLION)
21. GERMANY CONTRAST MEDIA/CONTRAST AGENT MARKET SIZE, 2020-2027 ($ MILLION)
22. ITALY CONTRAST MEDIA/CONTRAST AGENT MARKET SIZE, 2020-2027 ($ MILLION)
23. SPAIN CONTRAST MEDIA/CONTRAST AGENT MARKET SIZE, 2020-2027 ($ MILLION)
24. REST OF EUROPE CONTRAST MEDIA/CONTRAST AGENT MARKET SIZE, 2020-2027 ($ MILLION)
25. INDIA CONTRAST MEDIA/CONTRAST AGENT MARKET SIZE, 2020-2027 ($ MILLION)
26. CHINA CONTRAST MEDIA/CONTRAST AGENT MARKET SIZE, 2020-2027 ($ MILLION)
27. JAPAN CONTRAST MEDIA/CONTRAST AGENT MARKET SIZE, 2020-2027 ($ MILLION)
28. REST OF ASIA-PACIFIC CONTRAST MEDIA/CONTRAST AGENT MARKET SIZE, 2020-2027 ($ MILLION)
29. REST OF THE WORLD CONTRAST MEDIA/CONTRAST AGENT MARKET SIZE, 2020-2027 ($ MILLION)
